SecSonar.com

Penumbra, Inc. (PEN)

Penumbra, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Penumbra, Inc. (PEN) is a Medical - Devices company based in US with a market capitalization of $12.5B. Revenue grew 17.5% year-over-year and the company generated $174.9M in free cash flow. This page tracks PEN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4.5K employees · IPO Sep 18, 2015

Valuation

Valuation & price

$322.32 · as of May 17, 2026 · -10.3% vs 52w high

71.3

P/E ratio

Latest-FY diluted EPS

8.79

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$359$293$227Jul 25Dec 25Jul 26Jul 7, 25$248.37Jul 9, 25$244.39Jul 11, 25$237.94Jul 15, 25$236.41Jul 17, 25$230.10Jul 21, 25$228.86Jul 23, 25$233.39Jul 25, 25$233.10Jul 29, 25$227.15Jul 31, 25$252.27Aug 4, 25$240.39Aug 6, 25$239.99Aug 11, 25$239.50Aug 13, 25$257.38Aug 15, 25$253.02Aug 19, 25$253.20Aug 21, 25$251.37Aug 25, 25$264.17Aug 27, 25$266.93Aug 29, 25$272.64Sep 3, 25$269.71Sep 5, 25$281.46Sep 9, 25$287.09Sep 11, 25$276.40Sep 16, 25$262.96Sep 18, 25$257.75Sep 22, 25$253.66Sep 24, 25$253.65Sep 26, 25$253.37Sep 30, 25$253.32Oct 2, 25$253.49Oct 6, 25$255.61Oct 8, 25$258.95Oct 10, 25$260.49Oct 14, 25$254.94Oct 16, 25$253.84Oct 21, 25$249.00Oct 23, 25$253.51Oct 27, 25$247.99Oct 29, 25$233.37Oct 31, 25$227.37Nov 4, 25$235.08Nov 6, 25$264.61Nov 10, 25$270.55Nov 12, 25$280.29Nov 14, 25$280.07Nov 18, 25$278.10Nov 20, 25$279.79Nov 25, 25$298.71Nov 28, 25$293.17Dec 2, 25$287.71Dec 4, 25$294.72Dec 8, 25$294.83Dec 10, 25$303.07Dec 12, 25$312.02Dec 16, 25$308.10Dec 18, 25$315.35Dec 22, 25$320.85Dec 24, 25$315.86Dec 29, 25$314.89Jan 2, 26$309.42Jan 6, 26$316.97Jan 8, 26$315.54Jan 12, 26$319.47Jan 14, 26$313.43Jan 16, 26$350.78Jan 21, 26$357.68Jan 23, 26$359.26Jan 27, 26$359.40Jan 29, 26$357.00Feb 2, 26$356.99Feb 4, 26$339.92Feb 9, 26$339.05Feb 11, 26$338.26Feb 13, 26$339.30Feb 18, 26$341.32Feb 20, 26$339.36Feb 24, 26$339.59Feb 26, 26$341.94Mar 2, 26$342.30Mar 4, 26$339.61Mar 6, 26$338.64Mar 10, 26$336.74Mar 12, 26$334.99Mar 17, 26$338.00Mar 19, 26$337.35Mar 23, 26$335.56Mar 25, 26$336.27Mar 27, 26$335.10Mar 31, 26$328.37Apr 2, 26$330.36Apr 7, 26$329.96Apr 9, 26$329.52Apr 13, 26$331.48Apr 15, 26$332.42Apr 17, 26$332.13Apr 22, 26$332.21Apr 24, 26$329.89Apr 28, 26$325.99Apr 30, 26$326.48May 4, 26$324.65May 6, 26$324.19May 8, 26$322.23May 12, 26$322.79May 14, 26$322.97May 18, 26$326.54May 20, 26$327.38May 22, 26$328.69May 28, 26$318.95Jun 1, 26$318.95Jun 3, 26$319.37Jun 5, 26$320.53Jun 9, 26$321.06Jun 11, 26$318.32Jun 15, 26$318.21Jun 17, 26$316.16Jun 22, 26$316.20Jun 24, 26$316.36Jun 26, 26$316.63Jul 2, 26$318.57
$225.5452-week range$359.40
Loading valuation history…

Fundamentals

Key fundamentals

$12.5B

Market cap

17.5%

Revenue growth (YoY)

67.1%

Gross margin

$174.9M

Free cash flow (USD)

$32.8M

Net debt

0.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$263.3MFY 2017$333.8MFY 2018$444.9MFY 2019$547.4MFY 2020$560.4MFY 2021$747.6MFY 2022$847.1MFY 2023$1.1BFY 2024$1.2BFY 2025$1.4B
$263.3M$1.4B

Free cash flow by year

2016 → 2025

FY 2016$-26.4MFY 2017$-2.3MFY 2018$19.2MFY 2019$4.5MFY 2020$-58.0MFY 2021$-11.7MFY 2022$-75.0MFY 2023$82.1MFY 2024$147.3MFY 2025$174.9M
-$26.4M$174.9M

Gross margin by year

2021 → 2025

FY 202163.6%FY 202263.2%FY 202364.5%FY 202463.2%FY 202567.1%
63.6%67.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventMerger Proposal ApprovedMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • Insider sellInsider Sell $33K · 10b5-1 PlanGrewal Harpreet · Director · $32.8KApr 6, 2026Filing

Questions

Frequently asked questions

What is Penumbra, Inc.'s market cap?

Penumbra, Inc. (PEN) has a market capitalization of $12.5B.

What is PEN's P/E ratio?

PEN trades at a price-to-earnings ratio of 71.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PEN's price-to-book (P/B) ratio?

PEN trades at 8.79 times book value per share.

Are insiders buying PEN stock?

SEC Form 4 filings show no open-market insider buys at Penumbra, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Medical - Devices

ALGN

Align Technology, Inc.

$12.6B

SNN

Smith & Nephew plc

$12.7B

GMED

Globus Medical, Inc.

$11.1B

PODD

Insulet Corporation

$9.9B

MASI

Masimo Corporation

$9.3B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.